The best indicator for Roper Technologies (ROP)
We backtested 20 indicators across daily, weekly and hourly charts on real Roper Technologies (ROP) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
MACD
On the weekly chart, this is the strongest risk-adjusted edge we found for Roper Technologies (ROP) over ~34.4 years — trailing buy-and-hold by 5.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | MACD ✓ | Weekly | 10.5% | 0.58 | -38.3% | 49.3% | 71 | -5.9% |
| 2 | Stochastic ✓ | Daily | 9.8% | 0.56 | -54.0% | 76.0% | 167 | -6.9% |
| 3 | SMA 50/200 Cross ✓ | Daily | 11.1% | 0.54 | -48.2% | 54.5% | 22 | -5.6% |
| 4 | Rate of Change ✓ | Weekly | 9.4% | 0.51 | -54.0% | 49.1% | 106 | -7.0% |
| 5 | Bollinger Breakout ✓ | Weekly | 6.9% | 0.5 | -34.0% | 54.8% | 31 | -9.5% |
| 6 | RSI Trend (>50) ✓ | Weekly | 9.1% | 0.49 | -58.9% | 48.4% | 95 | -7.3% |
| 7 | EMA 50/200 Cross ✓ | Daily | 9.6% | 0.48 | -53.3% | 52.0% | 25 | -7.2% |
| 8 | Donchian Breakout ✓ | Weekly | 7.7% | 0.47 | -44.9% | 60.0% | 30 | -8.7% |
| 9 | EMA 20/50 Cross ✓ | Daily | 8.6% | 0.46 | -59.2% | 39.5% | 86 | -8.1% |
| 10 | Donchian Midline | Weekly | 8.1% | 0.45 | -56.1% | 50.9% | 110 | -8.2% |
| 11 | Williams %R ✓ | Daily | 6.7% | 0.41 | -54.5% | 72.9% | 229 | -10.0% |
| 12 | WaveTrend (8/6/4) ✓ | Daily | 6.8% | 0.4 | -53.7% | 77.6% | 125 | -10.0% |
| 13 | EMA 20/50 Cross ✓ | Weekly | 13.0% | 0.6 | -50.1% | 80.0% | 10 | -3.4% |
| 14 | Stochastic ✓ | Weekly | 5.6% | 0.39 | -48.4% | 86.2% | 29 | -10.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Roper Technologies (ROP), MACD on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.